Evaluating safety and efficacy of combining AB-729, VTP-300, nucleos(t)ide analogues and nivolumab (Opdivo®) WARMINSTER, Pa., June 21, 2023 (GLOBE NEWSWIRE)…
CINCINNATI, June 21, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology…
MELBOURNE, Australia and SAN FRANCISCO, June 21, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the…
Change in Total Motor Score June 2023 Webcast Presentation Neurofilament Light Chain (Nfl) percentage change from baseline in Cerebrospinal Fluid…
With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to four mental health reports to…
Company is well-positioned to advance robust clinical-stage CNS pipeline, following oversubscribed Series B financing earlier this yearBASEL, Switzerland, June 21,…
JERSEY CITY, N.J., June 21, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…
WILMETTE, Ill., June 21, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing…
Gohibic is now commercially available for hospitals in the U.S.Gohibic can be used under an Emergency Use Authorization (EUA) granted…
Jonathan Milner issues Open Letter to shareholders of Abcam plc Responds to Company’s assertions in its statement on 20 June…